Persistent Fetal SVT in a COVID-19 Positive Pregnancy

Wang, Gloria; Stapley, Eric; Peterson, Sara; Parrott, Jessica; Clark-Ganheart, Cecily A.

doi:10.1155/2022/9933520

Cited by 3 publications

(1 citation statement)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Furthermore, increased pulsatility and resistance indices of the umbilical and uterine artery in maternal-fetal Doppler patterns among pregnant women who recovered from COVID-19 were reported. A case report represented supraventricular tachycardia (SVT) in a fetus borne by a 26-year-old COVID-19-positive mother [ 87 ]. Fetus SVT is one of the most common arrhythmias in the presence of maternal COVID-19 infection [ 140 ].…”

Section: Discussionmentioning

confidence: 99%

Cardiovascular Complications of COVID-19 among Pregnant Women and Their Fetuses: A Systematic Review

Yaghoobpoor

Fathi

Vakili

et al. 2022

JCM

View full text Add to dashboard Cite

Background: COVID-19 is a viral infectious disease leading to a spectrum of clinical complications, especially cardiovascular. Evidence shows that this infection can potentially accompany a worse outcome in pregnant women. Cardiovascular complications in mothers and their fetuses are reported by previous studies. Objective: In this systematic review, we aim to investigate the cardiovascular complications of COVID-19 during pregnancy in the mothers and fetus, according to the published literature. Method: We systematically searched the online databases of PubMed, Scopus, Web of Science, and Google Scholar, using relevant keywords up to April 2022. We included all observational studies reporting cardiovascular complications among COVID-19-affected pregnant women and their fetuses. Results: We included 74 studies containing 47582 pregnant COVID-19 cases. Pre-eclampsia, hypertensive disorders, cardiomyopathy, heart failure, myocardial infarction, thrombosis formation, alterations in maternal–fetal Doppler patterns, and maternal and fetal arrhythmia were reported as cardiovascular complications. The highest incidences of pre-eclampsia/eclampsia among COVID-19 pregnant cases, reported by studies, were 69% and 62%, and the lowest were 0.5% and 3%. The highest and lowest incidences of fetal bradycardia were 20% and 3%, and regarding fetal tachycardia, 5.4% and 1%, respectively. Conclusion: SARS-CoV-2 infection during pregnancy can potentially be associated with cardiovascular complications in the mother, particularly pre-eclampsia and heart failure. Moreover, SARS-CoV-2 infection during pregnancy can potentially cause cardiovascular complications in the fetus, particularly arrhythmia.

show abstract

Section: Discussionmentioning

confidence: 99%

Cardiovascular Complications of COVID-19 among Pregnant Women and Their Fetuses: A Systematic Review

Yaghoobpoor

Fathi

Vakili

et al. 2022

JCM

View full text Add to dashboard Cite

show abstract

Incidence of Fetal Arrhythmia Before and During the COVID-19 Pandemic: A Single-Center Experience

Samples,

Patel,

Lee

et al. 2024

Pediatr Cardiol

View full text Add to dashboard Cite

Background: Fetal arrhythmias are rare and carry signi cant morbidity and mortality without appropriate treatment. Initial reports exist of fetal arrhythmia in the setting of maternal COVID-19 infection. Our study sought to evaluate incidence of fetal arrhythmia before and during the COVID-19 pandemic at our institution.Methods: This retrospective cohort study from a tertiary care fetal cardiac center utilized the institutional REDCap database to search fetal arrhythmia diagnostic codes. Medical records of mother-fetus dyads were reviewed and data was collected on diagnoses, gestational age, treatment regimen, and postnatal outcomes. Patients were divided into pre-COVID and peri-COVID segments.Results: 8368 total pregnancies were evaluated during the 7.3 years of study period. 45 patients (0.5%) had a signi cant fetal arrhythmia and were included in this study: 19 (42%) in the pre-COVID-19 group and 26 (58%) in the peri-COVID-19 group. No patients had associated congenital heart disease. There was a notable increase in the incidence of fetal supraventricular tachycardia (1.82 per 1000 vs 2.65 per 1000 pregnancies) and complete heart block (1.04 per 1000 vs 1.77 per 1000 pregnancies) but no apparent change in other tachyarrhythmias during the COVID era. The proportion of antibody-mediated complete heart block increased from 50% to 87.5%. There was also an increase in the percentage of supraventricular tachycardia patients requiring postnatal treatment during COVID-19 (53.8% vs 62.5%).Conclusions: Our experience shows an increased incidence of some fetal arrhythmia diagnoses during the COVID-19 pandemic. Additional multi-center studies will be necessary to fully evaluate the increased burden of fetal arrhythmias during the COVID-19 era as well as to elucidate etiology.

show abstract

Incidence of fetal arrhythmia before and during the COVID-19 pandemic: A single center experience

Samples,

Patel,

Lee

et al. 2023

Preprint

View full text Add to dashboard Cite

Background: Fetal arrhythmias are rare and carry significant morbidity and mortality without appropriate treatment. Initial reports exist of fetal arrhythmia in the setting of maternal COVID-19 infection. Our study sought to evaluate incidence of fetal arrhythmia before and during the COVID-19 pandemic at our institution. Methods: This retrospective cohort study from a tertiary care fetal cardiac center utilized the institutional REDCap database to search fetal arrhythmia diagnostic codes. Medical records of mother-fetus dyads were reviewed and data was collected on diagnoses, gestational age, treatment regimen, and postnatal outcomes. Patients were divided into pre-COVID and peri-COVID segments. Results: 8368 total pregnancies were evaluated during the 7.3 years of study period. 45 patients (0.5%) had a significant fetal arrhythmia and were included in this study: 19 (42%) in the pre-COVID-19 group and 26 (58%) in the peri-COVID-19 group. No patients had associated congenital heart disease. There was a notable increase in the incidence of fetal supraventricular tachycardia (1.82 per 1000 vs 2.65 per 1000 pregnancies) and complete heart block (1.04 per 1000 vs 1.77 per 1000 pregnancies) but no apparent change in other tachyarrhythmias during the COVID era. The proportion of antibody-mediated complete heart block increased from 50% to 87.5%. There was also an increase in the percentage of supraventricular tachycardia patients requiring postnatal treatment during COVID-19 (53.8% vs 62.5%). Conclusions: Our experience shows an increased incidence of some fetal arrhythmia diagnoses during the COVID-19 pandemic. Additional multi-center studies will be necessary to fully evaluate the increased burden of fetal arrhythmias during the COVID-19 era as well as to elucidate etiology.

show abstract

Persistent Fetal SVT in a COVID-19 Positive Pregnancy

Cited by 3 publications

References 17 publications

Cardiovascular Complications of COVID-19 among Pregnant Women and Their Fetuses: A Systematic Review

Cardiovascular Complications of COVID-19 among Pregnant Women and Their Fetuses: A Systematic Review

Incidence of Fetal Arrhythmia Before and During the COVID-19 Pandemic: A Single-Center Experience

Incidence of fetal arrhythmia before and during the COVID-19 pandemic: A single center experience

Contact Info

Product

Resources

About